What is the information from clinical trials used for?
In LEO Pharma, we use this information to:
- assess the safety of our trial medicines
- better understand the diseases we want to treat
- develop new medicines
- improve existing medicines
- find new ways of predicting how patients will respond to medicines.
In the future, this information may help reduce the need for new clinical trials.
LEO Pharma may use the data when applying to health authorities for permission to market a medicine. It can also be used to apply for an update to the conditions for medicines on the market, for instance, which types of patients may use the medicine. We may also use the data in reports to health authorities on possible side effects of the medicines.